zp7

ZP7 is a HIV-1 replication inhibitor.

NVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).

(R)-NVS-ZP7-4 is the R-isomer of NVS-ZP7-4, a Zinc transporter SLC39A7 (ZIP7) inhibitor and the first reported chemical tool to explore the effects of modulating ER zinc levels and investigate ZIP7 as a novel druggable node in the Notch pathway.

BDZ-P7 inhibits AMPA receptors GluA2, GluA1/2, GluA2/3, and GluA1 subunits with IC50 values of 3.03 μM, 3.14 μM, 3.19 μM, and 3.2 μM, respectively. It exhibits neuroprotective effects and is capable of restoring motor functions in mouse models of Parkinson’s disease.

Dapiglutide (ZP7570) is a long-acting dual agonist of both glucagon-like peptide-1 receptor (GLP-1R) and glucagon-like peptide-2 receptor (GLP-2R), with potential applications in short bowel syndrome (SBS) research.